CUBICIN RF
- Product NDC
- 67919-012
- 11-digit product format
- 679190012
- Labeler code
- 67919
- Product ID
- 67919-012_12165af7-0ba8-4dd6-a13c-9ac832e7fe8c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Daptomycin
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Merck Sharp & Dohme LLC
- Application
- NDA021572
- Marketing category
- NDA
- Marketing start
- 2016-09-13
- Marketing end
- 0000-00-00
- Substance
- DAPTOMYCIN
- Active strength
- 500 mg/10mL
- Pharmacologic classes
- Lipopeptide Antibacterial [EPC], Lipopeptides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 67919-012 | D | Discontinued by firm | 2026-08-17 | ||
| excluded package | package | 67919-012 | 67919-012-02 | D | Discontinued by firm | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 67919-012-02 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 67919-012-02 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 67919-012-02 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 67919-012-01 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 67919-012-02 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 67919-012-01 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 67919-012-01 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 67919-012-02 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 67919-012-01 | cdf11ea48f46… | ba0047e9e063… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 67919-012-02 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 67919-012-02 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 67919-012-02 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 67919-012-02 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 67919-012-02 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 67919-012-02 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 67919-012-02 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N021572-001 | CUBICIN | DAPTOMYCIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | ||
| N021572-002 | CUBICIN | DAPTOMYCIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2003-09-12 | |
| N021572-003 | CUBICIN RF | DAPTOMYCIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2016-07-06 |
Orange Book patents#
| Application-product | Patent | Expiration | Use code | Coverage / status | Submission date |
|---|---|---|---|---|---|
| N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | |
| N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021572-001 | CUBICIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | caaa826d4ba7… | ||
| 2026-08-18 06:07:40 | 2026-07 | N021572-002 | CUBICIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2003-09-12 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021572-003 | CUBICIN RF | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2016-07-06 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021572-001 | CUBICIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | N021572-002 | CUBICIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2003-09-12 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021572-003 | CUBICIN RF | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2016-07-06 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021572-001 | CUBICIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021572-002 | CUBICIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2003-09-12 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021572-003 | CUBICIN RF | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2016-07-06 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021572-001 | CUBICIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | N021572-002 | CUBICIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2003-09-12 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021572-003 | CUBICIN RF | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2016-07-06 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021572-001 | CUBICIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021572-002 | CUBICIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2003-09-12 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021572-003 | CUBICIN RF | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2016-07-06 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021572-001 | CUBICIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021572-002 | CUBICIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2003-09-12 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021572-003 | CUBICIN RF | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2016-07-06 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021572-001 | CUBICIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021572-002 | CUBICIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2003-09-12 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021572-003 | CUBICIN RF | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2016-07-06 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021572-001 | CUBICIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021572-002 | CUBICIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2003-09-12 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021572-003 | CUBICIN RF | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2016-07-06 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021572-001 | CUBICIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021572-002 | CUBICIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2003-09-12 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021572-003 | CUBICIN RF | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2016-07-06 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021572-001 | CUBICIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021572-002 | CUBICIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2003-09-12 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021572-003 | CUBICIN RF | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2016-07-06 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021572-001 | CUBICIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | N021572-002 | CUBICIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2003-09-12 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021572-003 | CUBICIN RF | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2016-07-06 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021572-001 | CUBICIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021572-002 | CUBICIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2003-09-12 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021572-003 | CUBICIN RF | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2016-07-06 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021572-001 | CUBICIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021572-002 | CUBICIN | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2003-09-12 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021572-003 | CUBICIN RF | 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | RLD | 2016-07-06 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021572-001 | CUBICIN | 250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | POWDER / INTRAVENOUS | 2003-09-12 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021572-002 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | N021572-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | N021572-002 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | N021572-002 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | N021572-002 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | N021572-002 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N021572-002 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | N021572-002 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | N021572-002 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N021572-002 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N021572-002 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021572-002 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021572-002 | AP | 1 | ea99ee380514… |
| 2023-05-13 08:27 UTC | 2023-05 | N021572-002 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | N021572-002 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N021572-002 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | N021572-002 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | N021572-002 | AP | 1 | e64feba35796… |
| 2022-07-09 03:26 UTC · 3 captures of this ZIP | 2022-07 | N021572-002 | AP | 1 | cb3db0bc1861… |
Observed Orange Book patent history#
| Captured | Edition | Application-product | Patent | Expiration | Use code | Coverage / status | Submission date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021572-002 | 8003673 | 2028-09-04 | U-1180 | 2011-09-23 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N021572-003 | 9138456 | 2030-11-23 | Drug product | 2016-08-01 | bb7c543d1eb4… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N021572-002 | NPP | 2020-03-29 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021572-002 | M-211 | 2020-09-01 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021572-003 | NPP | 2020-03-29 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | N021572-003 | M-211 | 2020-09-01 | 74a2ff9319b5… |
| 2020-12-22 03:56 UTC | 2020-12 | N021572-002 | NPP | 2020-03-29 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N021572-002 | M-211 | 2020-09-01 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N021572-003 | NPP | 2020-03-29 | 8869cabd3fbd… |
| 2020-12-22 03:56 UTC | 2020-12 | N021572-003 | M-211 | 2020-09-01 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N021572-002 | NPP | 2020-03-29 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N021572-002 | M-211 | 2020-09-01 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N021572-003 | NPP | 2020-03-29 | c0c555d07b60… |
| 2020-11-12 02:37 UTC | 2020-11 | N021572-003 | M-211 | 2020-09-01 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N021572-002 | NPP | 2020-03-29 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021572-002 | M-211 | 2020-09-01 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021572-003 | NPP | 2020-03-29 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | N021572-003 | M-211 | 2020-09-01 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N021572-002 | NPP | 2020-03-29 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N021572-002 | M-211 | 2020-09-01 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N021572-003 | NPP | 2020-03-29 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | N021572-003 | M-211 | 2020-09-01 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N021572-002 | NPP | 2020-03-29 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021572-002 | M-211 | 2020-09-01 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021572-003 | NPP | 2020-03-29 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | N021572-003 | M-211 | 2020-09-01 | ea99ee380514… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 45ca3ac7-6ee8-4e99-92a6-dc0b401e151a | Product name | 1 | 20250724 |
| 223d8260-7a4e-4ebd-9635-845422d6a8ad | Product name | 9 | 20240909 |
| ca803a62-3799-476f-bbc6-024f77cb0320 | Product name | 4 | 20240207 |
| cad85d83-8fb9-49f8-a5a6-a399af412964 | Product name | 1 | 20230922 |
| 8e59a5ed-f224-4156-b534-1ae4d0b6dfd7 | Product name | 1 | 20230721 |
| ea2c89ab-e8f8-425f-9693-c923fa1e1703 | Product name | 1 | 20220929 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 67919-012-01 | CUBICIN RF | 1 in 1 CARTON | INJECTION, POWDER, LYOPHILIZED, | 1 | 22 | |
| 67919-012-01 | CUBICIN RF | 10 mL in 1 VIAL, SINGLE-USE | INJECTION, POWDER, LYOPHILIZED, | 10 | 22 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 67919-012-02 | EA - Each | 67919-012 | a2ff6da3-4411-49f3-98a9-a2049a62f317 | 1 | 2016-10-06 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 404652 | CUBICIN 500 MG Injection | PSN | 0b1a8885-2198-4a0e-8105-0c76c1cba6c2 | 22 |
| 403920 | DAPTOmycin 500 MG Injection | PSN | 0b1a8885-2198-4a0e-8105-0c76c1cba6c2 | 22 |
| 404652 | daptomycin 500 MG Injection [Cubicin] | SBD | 0b1a8885-2198-4a0e-8105-0c76c1cba6c2 | 22 |
| 403920 | daptomycin 500 MG Injection | SCD | 0b1a8885-2198-4a0e-8105-0c76c1cba6c2 | 22 |
| 404652 | Cubicin 500 MG Injection | SY | 0b1a8885-2198-4a0e-8105-0c76c1cba6c2 | 22 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 67919-012-01 | 67919001201 | 1 VIAL, SINGLE-USE in 1 CARTON (67919-012-01) > 10 mL in 1 VIAL, SINGLE-USE | 2016-07-06 | 0000-00-00 | No | No | Current |
| 67919-012-02 | 67919001202 | 1 VIAL, SINGLE-USE in 1 CARTON (67919-012-02) > 10 mL in 1 VIAL, SINGLE-USE | 2016-09-13 | 0000-00-00 | No | No | Current |